130 related articles for article (PubMed ID: 21873548)
1. Prognostic implications of the IDH1 synonymous SNP rs11554137 in pediatric and adult AML: a report from the Children's Oncology Group and SWOG.
Ho PA; Kopecky KJ; Alonzo TA; Gerbing RB; Miller KL; Kuhn J; Zeng R; Ries RE; Raimondi SC; Hirsch BA; Oehler V; Hurwitz CA; Franklin JL; Gamis AS; Petersdorf SH; Anderson JE; Godwin JE; Reaman GH; Willman CL; Bernstein ID; Radich JP; Appelbaum FR; Stirewalt DL; Meshinchi S
Blood; 2011 Oct; 118(17):4561-6. PubMed ID: 21873548
[TBL] [Abstract][Full Text] [Related]
2. Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor.
Wagner K; Damm F; Göhring G; Görlich K; Heuser M; Schäfer I; Ottmann O; Lübbert M; Heit W; Kanz L; Schlimok G; Raghavachar AA; Fiedler W; Kirchner HH; Brugger W; Zucknick M; Schlegelberger B; Heil G; Ganser A; Krauter J
J Clin Oncol; 2010 May; 28(14):2356-64. PubMed ID: 20368538
[TBL] [Abstract][Full Text] [Related]
3. Molecular alterations of the IDH1 gene in AML: a Children's Oncology Group and Southwest Oncology Group study.
Ho PA; Alonzo TA; Kopecky KJ; Miller KL; Kuhn J; Zeng R; Gerbing RB; Raimondi SC; Hirsch BA; Oehler V; Hurwitz CA; Franklin JL; Gamis AS; Petersdorf SH; Anderson JE; Reaman GH; Baker LH; Willman CL; Bernstein ID; Radich JP; Appelbaum FR; Stirewalt DL; Meshinchi S
Leukemia; 2010 May; 24(5):909-13. PubMed ID: 20376086
[TBL] [Abstract][Full Text] [Related]
4. Characteristics and prognostic impact of IDH mutations in AML: a COG, SWOG, and ECOG analysis.
Zarnegar-Lumley S; Alonzo TA; Gerbing RB; Othus M; Sun Z; Ries RE; Wang J; Leonti A; Kutny MA; Ostronoff F; Radich JP; Appelbaum FR; Pogosova-Agadjanyan EL; O'Dwyer K; Tallman MS; Litzow M; Atallah E; Cooper TM; Aplenc RA; Abdel-Wahab O; Gamis AS; Luger S; Erba H; Levine R; Kolb EA; Stirewalt DL; Meshinchi S; Tarlock K
Blood Adv; 2023 Oct; 7(19):5941-5953. PubMed ID: 37267439
[TBL] [Abstract][Full Text] [Related]
5. Prognostic impact of the isocitrate dehydrogenase 1 single-nucleotide polymorphism rs11554137 in malignant gliomas.
Wang XW; Boisselier B; Rossetto M; Marie Y; Idbaih A; Mokhtari K; Gousias K; Hoang-Xuan K; Delattre JY; Simon M; Labussière M; Sanson M
Cancer; 2013 Feb; 119(4):806-13. PubMed ID: 23184331
[TBL] [Abstract][Full Text] [Related]
6. A case of Philadelphia chromosome-positive acute myeloid leukaemia with missense mutation R132c (c.394 c>t) and single nucleotide polymorphism rs11554137(G105G) in isocitrate dehydrogenase 1 gene.
Agarwal A; Jain M; Tewari S; Goel M; Kumar A
Natl Med J India; 2020; 33(3):146-148. PubMed ID: 33904417
[TBL] [Abstract][Full Text] [Related]
7. Clinical prognostic value of the isocitrate dehydrogenase 1 single-nucleotide polymorphism rs11554137 in glioblastoma.
Mistry AM; Vnencak-Jones CL; Mobley BC
J Neurooncol; 2018 Jun; 138(2):307-313. PubMed ID: 29423539
[TBL] [Abstract][Full Text] [Related]
8. Leukemic mutations in the methylation-associated genes DNMT3A and IDH2 are rare events in pediatric AML: a report from the Children's Oncology Group.
Ho PA; Kutny MA; Alonzo TA; Gerbing RB; Joaquin J; Raimondi SC; Gamis AS; Meshinchi S
Pediatr Blood Cancer; 2011 Aug; 57(2):204-9. PubMed ID: 21504050
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and prognostic value of IDH1 and IDH2 mutations in childhood AML: a study of the AML-BFM and DCOG study groups.
Damm F; Thol F; Hollink I; Zimmermann M; Reinhardt K; van den Heuvel-Eibrink MM; Zwaan CM; de Haas V; Creutzig U; Klusmann JH; Krauter J; Heuser M; Ganser A; Reinhardt D; Thiede C
Leukemia; 2011 Nov; 25(11):1704-10. PubMed ID: 21647152
[TBL] [Abstract][Full Text] [Related]
10. WT1 synonymous single nucleotide polymorphism rs16754 correlates with higher mRNA expression and predicts significantly improved outcome in favorable-risk pediatric acute myeloid leukemia: a report from the children's oncology group.
Ho PA; Kuhn J; Gerbing RB; Pollard JA; Zeng R; Miller KL; Heerema NA; Raimondi SC; Hirsch BA; Franklin JL; Lange B; Gamis AS; Alonzo TA; Meshinchi S
J Clin Oncol; 2011 Feb; 29(6):704-11. PubMed ID: 21189390
[TBL] [Abstract][Full Text] [Related]
11. [Clinical characteristics of newly diagnosed acute myeloid leukemia patients with NPM1 mutation].
Wei H; Zhang YQ; Lin D; Wang Y; Zhou CL; Liu BC; Li W; Rao Q; Wang M; Mi YC; Wang JX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):11-5. PubMed ID: 24598642
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and prognostic implications of WT1 mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group.
Ho PA; Zeng R; Alonzo TA; Gerbing RB; Miller KL; Pollard JA; Stirewalt DL; Heerema NA; Raimondi SC; Hirsch B; Franklin JL; Lange B; Meshinchi S
Blood; 2010 Aug; 116(5):702-10. PubMed ID: 20413658
[TBL] [Abstract][Full Text] [Related]
13. The prognostic effect of high diagnostic WT1 gene expression in pediatric AML depends on WT1 SNP rs16754 status: report from the Children's Oncology Group.
Ho PA; Alonzo TA; Gerbing RB; Kuhn J; Pollard JA; Hirsch B; Raimondi SC; Gamis AS; Meshinchi S
Pediatr Blood Cancer; 2014 Jan; 61(1):81-8. PubMed ID: 23956224
[TBL] [Abstract][Full Text] [Related]
14. A particular case of AML patient with the polymorphism G105G (rs11554137) and the missense mutation R132C in IDH1 gene.
Accetta R; Campiotti L; Elli L; Casalone R; Pallotti F
Clin Chem Lab Med; 2018 Dec; 57(2):e30-e33. PubMed ID: 30052515
[No Abstract] [Full Text] [Related]
15. The prognostic significance of IDH1 mutations in younger adult patients with acute myeloid leukemia is dependent on FLT3/ITD status.
Green CL; Evans CM; Hills RK; Burnett AK; Linch DC; Gale RE
Blood; 2010 Oct; 116(15):2779-82. PubMed ID: 20651067
[TBL] [Abstract][Full Text] [Related]
16. Outcome of Childhood Acute Myeloid Leukemia With FLT3-ITD Mutation: The Experience of Children's Cancer Hospital Egypt, 2007-17.
Semary SF; Hammad M; Soliman S; Yassen D; Gamal M; Albeltagy D; Hamdy N; Mahmoud S
Clin Lymphoma Myeloma Leuk; 2020 Aug; 20(8):e529-e541. PubMed ID: 32473792
[TBL] [Abstract][Full Text] [Related]
17. Correlation Between Isocitrate Dehydrogenase Gene Aberrations and Prognosis of Patients with Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis.
Xu Q; Li Y; Lv N; Jing Y; Xu Y; Li Y; Li W; Yao Z; Chen X; Huang S; Wang L; Li Y; Yu L
Clin Cancer Res; 2017 Aug; 23(15):4511-4522. PubMed ID: 28246275
[No Abstract] [Full Text] [Related]
18. Gemtuzumab Ozogamicin Reduces Relapse Risk in FLT3/ITD Acute Myeloid Leukemia: A Report from the Children's Oncology Group.
Tarlock K; Alonzo TA; Gerbing RB; Raimondi SC; Hirsch BA; Sung L; Pollard JA; Aplenc R; Loken MR; Gamis AS; Meshinchi S
Clin Cancer Res; 2016 Apr; 22(8):1951-7. PubMed ID: 26644412
[TBL] [Abstract][Full Text] [Related]
19. DNMT3A R882 Mutation with FLT3-ITD Positivity Is an Extremely Poor Prognostic Factor in Patients with Normal-Karyotype Acute Myeloid Leukemia after Allogeneic Hematopoietic Cell Transplantation.
Ahn JS; Kim HJ; Kim YK; Lee SS; Jung SH; Yang DH; Lee JJ; Kim NY; Choi SH; Jung CW; Jang JH; Kim HJ; Moon JH; Sohn SK; Won JH; Kim SH; Kim DD
Biol Blood Marrow Transplant; 2016 Jan; 22(1):61-70. PubMed ID: 26234722
[TBL] [Abstract][Full Text] [Related]
20. [IDH1 Gene Mutation and Its Clinical Significance in patients with Acute Myeloid Leukemia].
Wei JF; Qiu HY; Chen GH; Wang Y; Chen Z; Liu HJ; Mao JP; Jia T; Xue LG; Cai ZM; Zhu YX; Zhao LD
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1252-7. PubMed ID: 26524018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]